GabapentinThird Party Manufacturing in India

Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), though it does not directly interact with GABA receptors. Its primary mechanism of action is through high-affinity binding to the alpha-2-delta (α₂δ) subunit of voltage-gated calcium channels located on presynaptic neurons in the central nervous system. By binding to this auxiliary subunit, gabapentin reduces the influx of calcium into nerve terminals, which in turn decreases the release of excitatory neurotransmitters such as glutamate, substance P, and norepinephrine. This modulation of neurotransmitter release stabilizes neuronal excitability and reduces aberrant signaling in pain pathways and seizure circuits. The drug is not metabolized in the liver and does not induce or inhibit hepatic cytochrome P450 enzymes, which gives it a favorable drug interaction profile. Gabapentin has demonstrated efficacy in both epileptic and neuropathic pain models, with its analgesic effect mediated through both spinal and supraspinal mechanisms. Unlike traditional anticonvulsants that target sodium channels, gabapentin's selective calcium channel modulation provides a distinct therapeutic profile with a lower potential for cognitive side effects.

Therapeutic Uses

Gabapentin is prescribed for the treatment of:

• Postherpetic neuralgia: First-line therapy for chronic neuropathic pain following herpes zoster infection, reducing burning, stabbing, and allodynic pain.
• Partial onset seizures: Adjunctive therapy for adults and children aged 3 years and older with epilepsy, reducing seizure frequency when used with other anticonvulsants.
• Diabetic peripheral neuropathy: Off-label use as a first-line treatment for painful diabetic neuropathy, improving pain scores and quality of life.
• Restless legs syndrome: The prodrug gabapentin enacarbil is approved for moderate-to-severe primary RLS, and gabapentin itself is used off-label with good evidence.
• Fibromyalgia: Off-label use for pain management in fibromyalgia patients, often in combination with other agents.
• Alcohol withdrawal and dependence: Off-label use for maintaining abstinence and reducing cravings in alcohol use disorder.

Why Manufacturers Choose Gabapentin

Gabapentin is among the most prescribed neuropathic pain agents globally, with consistent demand driven by the rising prevalence of diabetes (diabetic neuropathy) and an aging population (postherpetic neuralgia). Indian manufacturers have established robust production capabilities for gabapentin capsules and tablets across multiple strengths, from 100mg to 800mg, catering to both domestic and export markets. The molecule's simple formulation requirements, established API supply chain, and stable regulatory pathway make it an attractive addition to any neuropsychiatry portfolio. Gabapentin is one of the most sought-after molecules for third party manufacturing in India, with strong demand from PCD franchise operators, hospital tender suppliers, and export distributors targeting regulated markets in Europe, Africa, and Asia.

Dosage Forms

• Capsule: 100mg, 300mg, 400mg
• Tablet: 600mg, 800mg
• Oral Solution: 250mg/5mL